BioMerieux buys diagnostics rival BioFire for $450 mln
September 04, 2013 at 05:04 AM EDT
PARIS, Sept 4 (Reuters) - French biotech firm BioMerieux will buy privately-owned U.S. rival BioFire Diagnostics for $450 million, in a deal aimed at consolidating its position as a major player in infectious disease diagnostics.
